Related Experiment Videos

Mortality after presentation with stent thrombosis is associated with time from index percutaneous coronary

Ehrin J Armstrong1, Thomas M Maddox1, Evan P Carey1

  • 1VA Eastern Colorado Health Care System and University of Colorado School of Medicine, Denver, CO.

American Heart Journal
|September 29, 2014
PubMed

Insights

Mortality risk after stent thrombosis (ST) varies by timing. Early ST (EST) carries the highest 30-day mortality, while very late ST (VLST) shows significantly lower risk compared to EST.

Area of Science:

  • Cardiology
  • Interventional Cardiology
  • Clinical Outcomes Research

Background:

  • Stent thrombosis (ST) is a serious complication after percutaneous coronary intervention.
  • The risk of mortality associated with ST may depend on the time elapsed since stent implantation.
  • Early, late, and very late ST events may have distinct underlying mechanisms and clinical implications.

Purpose of the Study:

  • To investigate the association between the timing of angiographically defined stent thrombosis (ST) and 30-day mortality.
  • To compare mortality risks across early ST (EST), late ST (LST), and very late ST (VLST) presentations.

Main Methods:

  • Retrospective analysis of 656 patients diagnosed with definite ST from the VA CART Program (2006-2012).
  • ST was categorized as EST (≤30 days), LST (31-365 days), and VLST (>365 days) post-implantation.
  • Log-rank tests and Cox regression models were used to assess unadjusted and adjusted 30-day mortality differences between ST timing groups.

Main Results:

  • The cohort included 129 (20%) EST, 138 (21%) LST, and 389 (59%) VLST cases.
  • Stent thrombosis timing was significantly associated with 30-day mortality (P=.04, adjusted).
  • Unadjusted mortality was 13% for EST, 6% for LST, and 3% for VLST. Adjusted analysis showed significantly lower mortality for VLST (HR 0.38) and nonsignificantly lower for LST (HR 0.5) compared to EST.

Conclusions:

  • Thirty-day mortality following definite ST is significantly influenced by the time from the initial percutaneous coronary intervention.
  • VLST is associated with a significantly lower 30-day mortality risk compared to EST.
  • These findings suggest that different pathophysiological mechanisms may underlie ST at various time points, impacting patient outcomes.
Abstract

Related Concept Videos